What are the lessons to be learned from the SARS epidemic? What are the driving forces and interrelations behind emerging infectious diseases? What are the strategic and institutional responses of multinational companies to biosecurity problems? Where are the "borders" at which exclusionary defenses to emerging infectious diseases are likely to be employed? How large was the economic impact of each of the major emerging infectious disease outbreaks in the past decade? What is the potential for related biological phenomena to affect the global economy, including the evolution of resistance to antibiotics, herbicides, and pesticides, and invasive species and bioterrorism? What new rapidly advancing technologies, systems and tools are being employed to monitor and understand biological systems?